Why should investors care about cancer therapy treatments? Seeking Alpha author Joe McCann explains why the FDA's recent approval on the first-ever treatment that genetically alters a patient's own cells to fight cancer is so important. Plus, how the purchase of Kite Pharma by Gilead Sciences means progress in the biotech industry.